04.26.2023
Your biggest challenges inspire us. That's why Emergent supports innovative drug makers that make the seemingly impossible possible. In our latest blog series, Case Study Corner, discover how we've helped our clients overcome their biggest challenges during the development and manufacturing process.
Summary: A mid size biotech company partnered with Emergent to characterize a multi-step lipid nanoparticle formulation process for a Phase III mRNA-LNP vaccine.
11.19.2021
Regardless of where a drug candidate is in the development pipeline, performing a technology transfer (tech transfer) presents...
08.19.2021
Mitigating risk is a key consideration for biopharmaceutical companies when planning their clinical trial material and/or drug...
03.01.2022
Innovation in cancer therapeutics is moving at an accelerated pace. Advancements in the development and manufacturing of...